Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
320 DKK | +3.23% | +7.02% | +156.00% |
04-17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
03-29 | Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024. | CI |
Chart calendar Gubra A/S
Upcoming events on Gubra A/S
Past events on Gubra A/S
05/12/2023 | Carlsquare Nordic Life Science Investor Day |
31/08/2023 05:00 | HC Andersen Capital Life Science Seminar |
30/05/2023 05:00 | ABGSC Life Science Summit |
Past sector events for Gubra A/S
17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 21:01 | CELCUITY INC.: Q1 2024 Earnings Release |
14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 13:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- GUBRA Stock
- Calendar Gubra A/S